Taken together, BDNF may have been upregulated in this study as a compensatory mechanism to improve metabolic dysfunction and insulin resistance in patients with NAFLD who have a reduction in activity. This evidence concerns the gene BDNF and metabolic dysfunction-associated steatotic liver disease.